Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$4.47M
26 trades · 3 insiders
Net · 90d
$-4.47M
Insiders on file
35
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | 13 | $0 | $370.7K | 2026-10-12 |
| Lin Shao-Lee | Chief Executive Officer, Director | 26 | $1000.0K | $3.52M | 2026-10-12 |
| Ray Sumita | Chief Legal Compliance Officer, Other | 13 | $0 | $583.0K | 2026-10-12 |
| Ahlers James M | Chief Financial Officer | 4 | $0 | $0 | 2026-07-30 |
| Borie Dominique Christian | Chief Medical Officer | 2 | $0 | $0 | 2026-07-13 |
| Meehan Viola Mong | Director | 2 | $0 | $0 | 2026-07-09 |
| Sarraf Pasha | Director | 10 | $99.7K | $0 | 2026-07-09 |
| Garzone Pamela | Director | 7 | $0 | $0 | 2026-07-09 |
| Camardo Daniel A. | Director | 2 | $0 | $0 | 2026-07-09 |
| Baker Daniel G. | CHIEF DEVELOPMENT OFFICER | 4 | $0 | $0 | 2026-04-09 |
| Warren Lucinda | CHIEF BUSINESS OFFICER | 4 | $0 | $0 | 2026-04-09 |
| Sandercock Colin | SVP, General Counsel and Sec | 31 | $252.1K | $665.5K | 2026-04-09 |
| Verheyen Patrick | Director | 4 | $0 | $0 | 2026-01-02 |
| Morich Frank | Director | 11 | $105.0K | $0 | 2026-01-02 |
| Kiener Peter A | Director | 18 | $0 | $392.3K | 2026-01-02 |
| Broadfoot Jill Marie | Director | 2 | $0 | $0 | 2026-01-02 |
| Azam Usman | CHIEF EXECUTIVE OFFICER | 1 | $0 | $0 | 2025-09-29 |
| Levisetti Matteo | Chief Medical Officer | 6 | $0 | $0 | 2025-03-21 |
| Millar Kerri-Ann | VP-Finance | 26 | $8.5K | $17.8K | 2025-03-21 |
| PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | 24 | $187.9K | $0 | 2025-03-21 |
| DRISCOLL FREDERICK W | Director | 8 | $0 | $0 | 2025-01-02 |
| Suri Anish | President and CSO | 52 | $19.8K | $890.5K | 2024-06-05 |
| Fox Michael J | Director | 1 | $0 | $0 | 2024-06-05 |
| NASSHORN PATRICIA | Chief Business Officer | 3 | $0 | $0 | 2023-02-16 |
| Fletcher Aaron G.L. | Director | 11 | $4.48M | $0 | 2023-01-03 |
| HOWSON TAMAR D | Director | 4 | $0 | $0 | 2023-01-03 |
| Gray Cameron | Director | 11 | $151.5K | $0 | 2022-06-14 |
| Pienta Kenneth | Chief Medical Officer | 23 | $56.0K | $550.7K | 2022-03-25 |
| Simon Barry J. | Director | 4 | $0 | $0 | 2021-01-04 |
| MARLETT CHRISTOPHER A | Director | 24 | $463.2K | $1.43M | 2020-01-02 |
| MCKNIGHT STEVEN L | Director | 3 | $0 | $0 | 2020-01-02 |
| Mancilla Bethany | SVP and Chief Business Officer | 3 | $0 | $0 | 2019-03-06 |
| DIGIANDOMENICO ANTHONY | Director | 7 | $275.5K | $0 | 2019-01-02 |
| Seidel Ronald D. III | EVP, Head of R&D | 1 | $0 | $0 | 2018-07-23 |
| Chaparro Rodolfo | EVP, Head of Immunology | 1 | $0 | $0 | 2018-07-23 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | S Sale | 2026-10-12 | 2026-10-14 | 1,144 | $28.05 | $32.1K | 47,817 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer, Dir | S Sale | 2026-10-12 | 2026-10-14 | 1,087 | $28.05 | $30.5K | 694,908 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer, Dir | S Sale | 2026-10-12 | 2026-10-14 | 10,000 | $27.50 | $275.0K | 695,995 | SEC↗ |
| Ray Sumita | Chief Legal Compliance Offic | S Sale | 2026-10-12 | 2026-10-14 | 1,844 | $28.05 | $51.7K | 116,701 | SEC↗ |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | M Exercise deriv | 2026-08-13 | 2026-08-17 | 13,647 | — | $0 | 27,295 | SEC↗ |
| Ray Sumita | Chief Legal Compliance Offic | M Exercise deriv | 2026-08-13 | 2026-08-17 | 18,196 | — | $0 | 36,393 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer | S Sale | 2026-08-13 | 2026-08-14 | 2,375 | $28.11 | $66.8K | 716,455 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer | S Sale | 2026-08-13 | 2026-08-14 | 10,460 | $29.48 | $308.4K | 705,995 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer | S Sale | 2026-08-13 | 2026-08-14 | 5,423 | $27.19 | $147.5K | 718,830 | SEC↗ |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | S Sale | 2026-08-13 | 2026-08-17 | 1,519 | $29.37 | $44.6K | 53,070 | SEC↗ |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | S Sale | 2026-08-13 | 2026-08-17 | 4,106 | $30.35 | $124.6K | 48,964 | SEC↗ |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | S Sale | 2026-08-13 | 2026-08-17 | 3 | $31.13 | $93 | 48,961 | SEC↗ |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | M Exercise | 2026-08-13 | 2026-08-17 | 13,647 | — | $0 | 54,589 | SEC↗ |
| Ray Sumita | Chief Legal Compliance Offic | S Sale | 2026-08-13 | 2026-08-17 | 4 | $31.13 | $125 | 118,545 | SEC↗ |
| Ray Sumita | Chief Legal Compliance Offic | S Sale | 2026-08-13 | 2026-08-17 | 6,442 | $30.35 | $195.5K | 118,549 | SEC↗ |
| Ray Sumita | Chief Legal Compliance Offic | M Exercise | 2026-08-13 | 2026-08-17 | 18,196 | — | $0 | 127,374 | SEC↗ |
| Ray Sumita | Chief Legal Compliance Offic | S Sale | 2026-08-13 | 2026-08-17 | 2,383 | $29.37 | $70.0K | 124,991 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer, Dir | S Sale | 2026-08-13 | 2026-08-14 | 10,460 | $29.48 | $308.4K | 705,995 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer, Dir | S Sale | 2026-08-13 | 2026-08-14 | 2,375 | $28.11 | $66.8K | 716,455 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer, Dir | S Sale | 2026-08-13 | 2026-08-14 | 5,423 | $27.19 | $147.5K | 718,830 | SEC↗ |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | M Exercise deriv | 2026-08-13 | 2026-08-17 | 13,647 | — | $0 | 27,295 | SEC↗ |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | S Sale | 2026-08-13 | 2026-08-17 | 3 | $31.13 | $93 | 48,961 | SEC↗ |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | S Sale | 2026-08-13 | 2026-08-17 | 4,106 | $30.35 | $124.6K | 48,964 | SEC↗ |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | S Sale | 2026-08-13 | 2026-08-17 | 1,519 | $29.37 | $44.6K | 53,070 | SEC↗ |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | M Exercise | 2026-08-13 | 2026-08-17 | 13,647 | — | $0 | 54,589 | SEC↗ |
| Ray Sumita | Chief Legal Compliance Offic | M Exercise deriv | 2026-08-13 | 2026-08-17 | 18,196 | — | $0 | 36,393 | SEC↗ |
| Ray Sumita | Chief Legal Compliance Offic | S Sale | 2026-08-13 | 2026-08-17 | 4 | $31.13 | $125 | 118,545 | SEC↗ |
| Ray Sumita | Chief Legal Compliance Offic | S Sale | 2026-08-13 | 2026-08-17 | 6,442 | $30.35 | $195.5K | 118,549 | SEC↗ |
| Ray Sumita | Chief Legal Compliance Offic | S Sale | 2026-08-13 | 2026-08-17 | 2,383 | $29.37 | $70.0K | 124,991 | SEC↗ |
| Ray Sumita | Chief Legal Compliance Offic | M Exercise | 2026-08-13 | 2026-08-17 | 18,196 | — | $0 | 127,374 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer | M Exercise deriv | 2026-08-12 | 2026-08-14 | 109,179 | — | $0 | 218,358 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer | S Sale | 2026-08-12 | 2026-08-14 | 5,775 | $27.75 | $160.3K | 724,253 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer | M Exercise | 2026-08-12 | 2026-08-14 | 109,179 | — | $0 | 764,253 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer | S Sale | 2026-08-12 | 2026-08-14 | 34,225 | $26.99 | $923.7K | 730,028 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer, Dir | M Exercise deriv | 2026-08-12 | 2026-08-14 | 109,179 | — | $0 | 218,358 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer, Dir | S Sale | 2026-08-12 | 2026-08-14 | 5,775 | $27.75 | $160.3K | 724,253 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer, Dir | S Sale | 2026-08-12 | 2026-08-14 | 34,225 | $26.99 | $923.7K | 730,028 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer, Dir | M Exercise | 2026-08-12 | 2026-08-14 | 109,179 | — | $0 | 764,253 | SEC↗ |
| Ahlers James M | Chief Financial Officer | A Award deriv | 2026-07-30 | 2026-08-03 | 51,000 | — | $0 | 51,000 | SEC↗ |
| Ahlers James M | Chief Financial Officer | A Award | 2026-07-30 | 2026-08-03 | 25,500 | — | $0 | 25,500 | SEC↗ |
| Ahlers James M | Chief Financial Officer | A Award deriv | 2026-07-30 | 2026-08-03 | 51,000 | — | $0 | 51,000 | SEC↗ |
| Ahlers James M | Chief Financial Officer | A Award | 2026-07-30 | 2026-08-03 | 25,500 | — | $0 | 25,500 | SEC↗ |
| Borie Dominique Christian | Chief Medical Officer | A Award deriv | 2026-07-13 | 2026-07-15 | 63,000 | — | $0 | 63,000 | SEC↗ |
| Borie Dominique Christian | Chief Medical Officer | A Award | 2026-07-13 | 2026-07-15 | 31,500 | — | $0 | 31,500 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer | A Award deriv | 2026-07-09 | 2026-07-10 | 327,537 | — | $0 | 327,537 | SEC↗ |
| Ray Sumita | Chief Legal Compliance Offic | A Award deriv | 2026-07-09 | 2026-07-10 | 54,589 | — | $0 | 54,589 | SEC↗ |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | A Award deriv | 2026-07-09 | 2026-07-10 | 40,942 | — | $0 | 40,942 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer | A Award | 2026-07-09 | 2026-07-10 | 327,537 | — | $0 | 655,074 | SEC↗ |
| Ray Sumita | Chief Legal Compliance Offic | A Award | 2026-07-09 | 2026-07-10 | 54,589 | — | $0 | 109,178 | SEC↗ |
| Meluzio Michael Vincent | VP, Prin. Accounting Officer | A Award | 2026-07-09 | 2026-07-10 | 40,942 | — | $0 | 40,942 | SEC↗ |
| Meehan Viola Mong | Director | A Award | 2026-07-09 | 2026-07-10 | 21,800 | — | $0 | 21,800 | SEC↗ |
| Sarraf Pasha | Director | A Award | 2026-07-09 | 2026-07-10 | 21,800 | — | $0 | 32,595 | SEC↗ |
| Camardo Daniel A. | Director | A Award | 2026-07-09 | 2026-07-10 | 21,800 | — | $0 | 21,800 | SEC↗ |
| Garzone Pamela | Director | A Award | 2026-07-09 | 2026-07-10 | 21,800 | — | $0 | 21,800 | SEC↗ |
| Garzone Pamela | Director | A Award | 2026-07-09 | 2026-08-28 | 18,900 | — | $0 | 18,900 | SEC↗ |
| Sarraf Pasha | Director | A Award | 2026-07-09 | 2026-08-28 | 18,400 | — | $0 | 29,195 | SEC↗ |
| Sarraf Pasha | Director | A Award | 2026-07-09 | 2026-08-28 | 18,400 | — | $0 | 29,195 | SEC↗ |
| Garzone Pamela | Director | A Award | 2026-07-09 | 2026-08-28 | 18,900 | — | $0 | 18,900 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer | A Award deriv | 2026-06-01 | 2026-07-30 | 45,453 | — | $0 | 45,453 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer | A Award deriv | 2026-06-01 | 2026-07-30 | 90,906 | $11.00 | $1000.0K | 90,906 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer | P Buy deriv | 2026-06-01 | 2026-06-03 | 90,906 | $11.00 | $1000.0K | 90,906 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer | P Buy deriv | 2026-06-01 | 2026-06-03 | 45,453 | — | $0 | 45,453 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer, Dir | A Award deriv | 2026-06-01 | 2026-07-30 | 45,453 | — | — | 45,453 | SEC↗ |
| Lin Shao-Lee | Chief Executive Officer, Dir | A Award deriv | 2026-06-01 | 2026-07-30 | 90,906 | $11.00 | $1000.0K | 90,906 | SEC↗ |
| Meehan Viola Mong | Director | A Award deriv | 2026-05-30 | 2026-06-02 | 1,626 | — | $0 | 1,626 | SEC↗ |
| Camardo Daniel A. | Director | A Award deriv | 2026-05-30 | 2026-06-08 | 1,626 | — | $0 | 1,626 | SEC↗ |
| Lin Shao-Lee | CHIEF EXECUTIVE OFFICER | A Award deriv | 2026-05-03 | 2026-05-07 | 655,074 | — | $0 | 655,074 | SEC↗ |
| Lin Shao-Lee | CHIEF EXECUTIVE OFFICER | A Award | 2026-05-03 | 2026-05-07 | 327,537 | — | $0 | 327,537 | SEC↗ |
| Baker Daniel G. | CHIEF DEVELOPMENT OFFICER | A Award deriv | 2026-04-09 | 2026-04-10 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Warren Lucinda | CHIEF BUSINESS OFFICER | A Award deriv | 2026-04-09 | 2026-04-10 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Sandercock Colin | SVP, GENERAL COUNSEL | A Award deriv | 2026-04-09 | 2026-04-10 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Sarraf Pasha | Director | A Award deriv | 2026-01-02 | 2026-01-06 | 24,400 | — | $0 | 24,400 | SEC↗ |
| Verheyen Patrick | Director | A Award deriv | 2026-01-02 | 2026-01-06 | 24,400 | — | $0 | 24,400 | SEC↗ |
| Garzone Pamela | Director | A Award deriv | 2026-01-02 | 2026-01-06 | 24,400 | — | $0 | 24,400 | SEC↗ |
| Morich Frank | Director | A Award deriv | 2026-01-02 | 2026-01-06 | 24,400 | — | $0 | 24,400 | SEC↗ |
| Broadfoot Jill Marie | Director | A Award deriv | 2026-01-02 | 2026-01-06 | 24,400 | — | $0 | 24,400 | SEC↗ |
| Kiener Peter A | Director | A Award deriv | 2026-01-02 | 2026-01-06 | 24,400 | — | $0 | 24,400 | SEC↗ |
| Sarraf Pasha | Director | P Buy | 2025-12-30 | 2026-01-02 | 78,116 | $0.31 | $24.2K | 246,440 | SEC↗ |
| Sarraf Pasha | Director | P Buy | 2025-12-30 | 2026-01-02 | 4,229 | $0.31 | $1.3K | 4,229 | SEC↗ |
| Sarraf Pasha | Director | P Buy | 2025-12-30 | 2026-01-02 | 77,148 | $0.30 | $23.1K | 81,377 | SEC↗ |
| Sarraf Pasha | Director | P Buy | 2025-12-30 | 2026-01-02 | 86,947 | $0.32 | $27.8K | 168,324 | SEC↗ |
| Sarraf Pasha | Director | P Buy | 2025-12-30 | 2026-01-02 | 77,417 | $0.30 | $23.2K | 323,857 | SEC↗ |
| Sandercock Colin | SVP, GENERAL COUNSEL | A Award deriv | 2025-12-03 | 2025-12-05 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Azam Usman | CHIEF EXECUTIVE OFFICER | A Award deriv | 2025-09-29 | 2025-10-02 | 1,875,000 | — | $0 | 1,875,000 | SEC↗ |
| Baker Daniel G. | CHIEF DEVELOPMENT OFFICER | A Award deriv | 2025-09-29 | 2025-11-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Warren Lucinda | CHIEF BUSINESS OFFICER | A Award deriv | 2025-09-29 | 2025-11-25 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Sandercock Colin | SVP, GENERAL COUNSEL | A Award deriv | 2025-09-26 | 2025-12-05 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Broadfoot Jill Marie | Director | A Award deriv | 2025-06-04 | 2025-06-06 | 48,800 | — | $0 | 48,800 | SEC↗ |
| Levisetti Matteo | Chief Medical Officer | A Award deriv | 2025-03-21 | 2025-03-25 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Warren Lucinda | CHIEF BUSINESS OFFICER | A Award deriv | 2025-03-21 | 2025-03-25 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Sandercock Colin | SVP, GENERAL COUNSEL | A Award deriv | 2025-03-21 | 2025-03-25 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Baker Daniel G. | CHIEF DEVELOPMENT OFFICER | A Award deriv | 2025-03-21 | 2025-03-25 | 100,000 | — | $0 | 100,000 | SEC↗ |
| PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | A Award deriv | 2025-03-21 | 2025-03-25 | 450,000 | — | $0 | 450,000 | SEC↗ |
| Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | A Award deriv | 2025-03-21 | 2025-03-25 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Sarraf Pasha | Director | A Award deriv | 2025-03-10 | 2025-03-12 | 48,800 | — | $0 | 48,800 | SEC↗ |
| Garzone Pamela | Director | A Award deriv | 2025-01-02 | 2025-01-03 | 24,400 | — | $0 | 24,400 | SEC↗ |
| Verheyen Patrick | Director | A Award deriv | 2025-01-02 | 2025-01-03 | 24,400 | — | $0 | 24,400 | SEC↗ |
| Kiener Peter A | Director | A Award deriv | 2025-01-02 | 2025-01-03 | 24,400 | — | $0 | 24,400 | SEC↗ |
| DRISCOLL FREDERICK W | Director | A Award deriv | 2025-01-02 | 2025-01-03 | 24,400 | — | $0 | 24,400 | SEC↗ |
| Morich Frank | Director | A Award deriv | 2025-01-02 | 2025-01-03 | 24,400 | — | $0 | 24,400 | SEC↗ |
| PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | P Buy | 2024-12-16 | 2024-12-18 | 30,000 | $1.03 | $30.9K | 164,578 | SEC↗ |
| Baker Daniel G. | CHIEF DEVELOPMENT OFFICER | A Award deriv | 2024-11-25 | 2024-11-29 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Warren Lucinda | CHIEF BUSINESS OFFICER | A Award deriv | 2024-09-03 | 2024-09-05 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | A Award deriv | 2024-06-05 | 2024-06-07 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Sandercock Colin | SVP, GENERAL COUNSEL | A Award deriv | 2024-06-05 | 2024-06-07 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Fox Michael J | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 48,800 | — | $0 | 48,800 | SEC↗ |
| Suri Anish | PRESIDENT AND CSO | A Award deriv | 2024-06-05 | 2024-06-07 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Levisetti Matteo | Chief Medical Officer | A Award deriv | 2024-06-05 | 2024-06-07 | 125,000 | — | $0 | 125,000 | SEC↗ |
| PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | A Award deriv | 2024-03-06 | 2024-03-08 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Levisetti Matteo | Chief Medical Officer | A Award deriv | 2024-03-06 | 2024-03-08 | 260,000 | — | $0 | 260,000 | SEC↗ |
| Suri Anish | PRESIDENT AND CSO | A Award deriv | 2024-03-06 | 2024-03-08 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | A Award deriv | 2024-03-06 | 2024-03-08 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Sandercock Colin | SVP, GENERAL COUNSEL | A Award deriv | 2024-03-06 | 2024-03-08 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Levisetti Matteo | Chief Medical Officer | A Award deriv | 2024-02-20 | 2024-02-22 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Morich Frank | Director | A Award deriv | 2024-01-02 | 2024-01-04 | 24,400 | — | $0 | 24,400 | SEC↗ |
| Verheyen Patrick | Director | A Award deriv | 2024-01-02 | 2024-01-04 | 24,400 | — | $0 | 24,400 | SEC↗ |
| DRISCOLL FREDERICK W | Director | A Award deriv | 2024-01-02 | 2024-01-04 | 24,400 | — | $0 | 24,400 | SEC↗ |
| Kiener Peter A | Director | A Award deriv | 2024-01-02 | 2024-01-04 | 24,400 | — | $0 | 24,400 | SEC↗ |
| Garzone Pamela | Director | A Award deriv | 2024-01-02 | 2024-01-04 | 24,400 | — | $0 | 24,400 | SEC↗ |
| Suri Anish | PRESIDENT AND CSO | P Buy | 2023-08-25 | 2023-08-29 | 4,000 | $2.76 | $11.0K | 135,638 | SEC↗ |
| PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | P Buy | 2023-08-14 | 2023-08-16 | 3,000 | $2.86 | $8.6K | 134,578 | SEC↗ |
| Suri Anish | PRESIDENT AND CSO | A Award deriv | 2023-07-21 | 2023-07-25 | 124,125 | — | $0 | 124,125 | SEC↗ |
| Sandercock Colin | SVP, GENERAL COUNSEL | A Award deriv | 2023-07-21 | 2023-07-25 | 75,000 | — | $0 | 75,000 | SEC↗ |
| PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | A Award deriv | 2023-07-21 | 2023-07-25 | 450,000 | — | $0 | 450,000 | SEC↗ |
| Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | A Award deriv | 2023-07-21 | 2023-07-25 | 113,000 | — | $0 | 113,000 | SEC↗ |
| Levisetti Matteo | Chief Medical Officer | A Award deriv | 2023-07-21 | 2023-07-25 | 82,500 | — | $0 | 82,500 | SEC↗ |
| Garzone Pamela | Director | A Award deriv | 2023-04-19 | 2023-04-21 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Verheyen Patrick | Director | A Award deriv | 2023-04-11 | 2023-04-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Kiener Peter A | Director | M Exercise deriv | 2023-03-23 | 2023-03-27 | 9,682 | — | $0 | 96,062 | SEC↗ |
| Kiener Peter A | Director | S Sale | 2023-03-23 | 2023-03-27 | 9,325 | $3.28 | $30.6K | 357 | SEC↗ |
| Kiener Peter A | Director | M Exercise | 2023-03-23 | 2023-03-27 | 9,682 | $2.86 | $27.7K | 9,682 | SEC↗ |
| Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | A Award deriv | 2023-02-16 | 2023-02-21 | 124,000 | — | $0 | 124,000 | SEC↗ |
| PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | A Award deriv | 2023-02-16 | 2023-02-21 | 324,000 | — | $0 | 324,000 | SEC↗ |
| Sandercock Colin | SVP, GENERAL COUNSEL | A Award deriv | 2023-02-16 | 2023-02-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Suri Anish | PRESIDENT AND CSO | A Award deriv | 2023-02-16 | 2023-02-21 | 125,500 | — | $0 | 125,500 | SEC↗ |
| NASSHORN PATRICIA | Chief Business Officer | A Award deriv | 2023-02-16 | 2023-02-21 | 97,900 | — | $0 | 97,900 | SEC↗ |
| Levisetti Matteo | Chief Medical Officer | A Award deriv | 2023-01-17 | 2023-01-19 | 110,000 | — | $0 | 110,000 | SEC↗ |
| DRISCOLL FREDERICK W | Director | A Award deriv | 2023-01-03 | 2023-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Fletcher Aaron G.L. | Director | A Award deriv | 2023-01-03 | 2023-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HOWSON TAMAR D | Director | A Award deriv | 2023-01-03 | 2023-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Kiener Peter A | Director | A Award deriv | 2023-01-03 | 2023-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Morich Frank | Director | A Award deriv | 2023-01-03 | 2023-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | F Tax w/h | 2022-08-22 | 2022-08-23 | 2,828 | $3.05 | $8.6K | 14,311 | SEC↗ |
| Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2022-08-21 | 2022-08-23 | 6,667 | — | $0 | 0 | SEC↗ |
| Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | M Exercise | 2022-08-21 | 2022-08-23 | 6,667 | — | $0 | 17,139 | SEC↗ |
| Gray Cameron | Director | X Exercise deriv | 2022-06-14 | 2022-06-16 | 61,111 | — | $0 | 0 | SEC↗ |
| Gray Cameron | Director | F Tax w/h | 2022-06-14 | 2022-06-16 | 51,562 | $3.20 | $165.0K | 687,049 | SEC↗ |
| Gray Cameron | Director | X Exercise | 2022-06-14 | 2022-06-16 | 61,111 | $2.70 | $165.0K | 738,611 | SEC↗ |
| Morich Frank | Director | P Buy | 2022-05-27 | 2022-05-31 | 28,000 | $3.75 | $105.0K | 28,000 | SEC↗ |
| Fletcher Aaron G.L. | Director | P Buy | 2022-05-24 | 2022-05-25 | 55,000 | $3.34 | $183.7K | 940,000 | SEC↗ |
| Fletcher Aaron G.L. | Director | P Buy | 2022-05-23 | 2022-05-25 | 150,000 | $3.52 | $528.0K | 885,000 | SEC↗ |
| PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2022-03-31 | 2022-04-04 | 75,000 | — | $0 | 0 | SEC↗ |
| Suri Anish | PRESIDENT AND CSO | M Exercise deriv | 2022-03-31 | 2022-04-04 | 16,668 | — | $0 | 0 | SEC↗ |
| Fletcher Aaron G.L. | Director | P Buy | 2022-03-31 | 2022-04-04 | 735,000 | $4.76 | $3.50M | 735,000 | SEC↗ |
| PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | M Exercise | 2022-03-31 | 2022-04-04 | 75,000 | — | $0 | 173,700 | SEC↗ |
| PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | G Gift | 2022-03-31 | 2022-04-04 | 10,000 | — | $0 | 131,578 | SEC↗ |
| PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | F Tax w/h | 2022-03-31 | 2022-04-04 | 32,122 | $4.88 | $156.8K | 141,578 | SEC↗ |
| Suri Anish | PRESIDENT AND CSO | M Exercise | 2022-03-31 | 2022-04-04 | 16,668 | — | $0 | 110,706 | SEC↗ |
| Suri Anish | PRESIDENT AND CSO | F Tax w/h | 2022-03-31 | 2022-04-04 | 7,068 | $4.88 | $34.5K | 103,638 | SEC↗ |
| Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | A Award deriv | 2022-03-25 | 2022-03-29 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | A Award deriv | 2022-03-25 | 2022-03-29 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Pienta Kenneth | Chief Medical Officer | A Award deriv | 2022-03-25 | 2022-03-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Sandercock Colin | SVP, GENERAL COUNSEL | A Award deriv | 2022-03-25 | 2022-03-29 | 16,667 | — | $0 | 16,667 | SEC↗ |
| Suri Anish | PRESIDENT AND CSO | A Award deriv | 2022-03-25 | 2022-03-29 | 21,333 | — | $0 | 21,333 | SEC↗ |
| NASSHORN PATRICIA | Chief Business Officer | A Award deriv | 2022-03-25 | 2022-03-29 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | A Award deriv | 2022-02-09 | 2022-03-29 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Sandercock Colin | SVP, GENERAL COUNSEL | A Award deriv | 2022-02-09 | 2022-03-29 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Suri Anish | PRESIDENT AND CSO | A Award deriv | 2022-02-09 | 2022-03-29 | 82,000 | — | $0 | 82,000 | SEC↗ |
| Gray Cameron | Director | A Award deriv | 2022-01-03 | 2022-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DRISCOLL FREDERICK W | Director | A Award deriv | 2022-01-03 | 2022-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HOWSON TAMAR D | Director | A Award deriv | 2022-01-03 | 2022-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Morich Frank | Director | A Award deriv | 2022-01-03 | 2022-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Kiener Peter A | Director | A Award deriv | 2022-01-03 | 2022-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Fletcher Aaron G.L. | Director | A Award deriv | 2022-01-03 | 2022-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Pienta Kenneth | Chief Medical Officer | A Award deriv | 2021-12-20 | 2021-12-21 | 80,000 | — | $0 | 80,000 | SEC↗ |
| NASSHORN PATRICIA | Chief Business Officer | A Award deriv | 2021-12-15 | 2022-01-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Kiener Peter A | Director | M Exercise deriv | 2021-11-16 | 2021-11-17 | 1,361 | — | $0 | 105,744 | SEC↗ |
| Kiener Peter A | Director | M Exercise | 2021-11-16 | 2021-11-17 | 1,361 | $2.86 | $3.9K | 1,361 | SEC↗ |
| Kiener Peter A | Director | S Sale | 2021-11-16 | 2021-11-17 | 1,361 | $18.02 | $24.5K | 0 | SEC↗ |
| Suri Anish | President and CSO | M Exercise deriv | 2021-11-15 | 2021-11-17 | 8,000 | — | $0 | 10,000 | SEC↗ |
| Kiener Peter A | Director | M Exercise deriv | 2021-11-15 | 2021-11-17 | 18,815 | — | $0 | 107,105 | SEC↗ |
| Suri Anish | President and CSO | M Exercise | 2021-11-15 | 2021-11-17 | 8,000 | $8.26 | $66.1K | 102,038 | SEC↗ |
| Suri Anish | President and CSO | S Sale | 2021-11-15 | 2021-11-17 | 8,000 | $18.05 | $144.4K | 94,038 | SEC↗ |
| Kiener Peter A | Director | S Sale | 2021-11-15 | 2021-11-17 | 18,815 | $17.92 | $337.2K | 0 | SEC↗ |
| Kiener Peter A | Director | M Exercise | 2021-11-15 | 2021-11-17 | 18,815 | $2.86 | $53.8K | 18,815 | SEC↗ |
| Suri Anish | President and CSO | M Exercise deriv | 2021-11-11 | 2021-11-15 | 20,000 | — | $0 | 105,000 | SEC↗ |
| Suri Anish | President and CSO | M Exercise | 2021-11-11 | 2021-11-15 | 20,000 | $6.42 | $128.4K | 114,038 | SEC↗ |
| Suri Anish | President and CSO | S Sale | 2021-11-11 | 2021-11-15 | 20,000 | $15.07 | $301.4K | 94,038 | SEC↗ |
| Suri Anish | PRESIDENT AND CSO | F Tax w/h | 2021-10-06 | 2021-10-08 | 14,134 | $12.97 | $183.3K | 94,038 | SEC↗ |
| Suri Anish | PRESIDENT AND CSO | M Exercise deriv | 2021-10-03 | 2021-10-08 | 33,334 | — | $0 | 0 | SEC↗ |
| Suri Anish | PRESIDENT AND CSO | M Exercise | 2021-10-03 | 2021-10-08 | 33,334 | — | $0 | 108,172 | SEC↗ |
| Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2021-10-01 | 2021-10-05 | 1,251 | — | $0 | 53,749 | SEC↗ |
| Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | S Sale | 2021-10-01 | 2021-10-05 | 1,251 | $14.21 | $17.8K | 10,472 | SEC↗ |
| Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | M Exercise | 2021-10-01 | 2021-10-05 | 1,251 | $7.50 | $9.4K | 11,723 | SEC↗ |
| PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2021-09-30 | 2021-10-08 | 75,000 | — | $0 | 75,000 | SEC↗ |
| PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | M Exercise | 2021-09-30 | 2021-10-08 | 75,000 | — | $0 | 130,377 | SEC↗ |
| PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | F Tax w/h | 2021-09-30 | 2021-10-08 | 31,677 | $14.57 | $461.5K | 98,700 | SEC↗ |
| PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | P Buy | 2021-09-24 | 2021-09-27 | 3,400 | $14.72 | $50.0K | 55,377 | SEC↗ |
| Suri Anish | PRESIDENT AND CSO | M Exercise deriv | 2021-09-23 | 2021-09-27 | 20,000 | — | $0 | 125,000 | SEC↗ |
| Suri Anish | PRESIDENT AND CSO | S Sale | 2021-09-23 | 2021-09-27 | 20,000 | $15.23 | $304.6K | 74,838 | SEC↗ |
| Suri Anish | PRESIDENT AND CSO | M Exercise | 2021-09-23 | 2021-09-27 | 20,000 | $6.42 | $128.4K | 94,838 | SEC↗ |
| Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2021-08-23 | 2021-10-05 | 6,667 | — | $0 | 6,667 | SEC↗ |
| Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | F Tax w/h | 2021-08-23 | 2021-10-05 | 1,961 | — | $0 | 10,472 | SEC↗ |
| Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | M Exercise | 2021-08-23 | 2021-10-05 | 6,667 | — | $0 | 12,433 | SEC↗ |
| Pienta Kenneth | Chief Medical Officer | M Exercise deriv | 2021-03-16 | 2021-03-17 | 439 | — | $0 | 133,567 | SEC↗ |
| Pienta Kenneth | Chief Medical Officer | S Sale | 2021-03-16 | 2021-03-17 | 439 | $15.09 | $6.6K | 2,000 | SEC↗ |
| Pienta Kenneth | Chief Medical Officer | M Exercise | 2021-03-16 | 2021-03-17 | 439 | $5.00 | $2.2K | 2,439 | SEC↗ |
| Pienta Kenneth | Chief Medical Officer | M Exercise deriv | 2021-03-15 | 2021-03-17 | 13,000 | — | $0 | 134,006 | SEC↗ |
| Pienta Kenneth | Chief Medical Officer | M Exercise | 2021-03-15 | 2021-03-17 | 13,000 | $5.00 | $65.0K | 15,000 | SEC↗ |
| Pienta Kenneth | Chief Medical Officer | S Sale | 2021-03-15 | 2021-03-17 | 13,000 | $15.10 | $196.3K | 2,000 | SEC↗ |
| Pienta Kenneth | Chief Medical Officer | M Exercise deriv | 2021-02-17 | 2021-02-18 | 1,280 | — | $0 | 0 | SEC↗ |
| Pienta Kenneth | Chief Medical Officer | M Exercise deriv | 2021-02-17 | 2021-02-18 | 2,994 | — | $0 | 147,006 | SEC↗ |
| Pienta Kenneth | Chief Medical Officer | M Exercise | 2021-02-17 | 2021-02-18 | 1,280 | $2.86 | $3.7K | 3,280 | SEC↗ |
| Pienta Kenneth | Chief Medical Officer | S Sale | 2021-02-17 | 2021-02-18 | 4,274 | $15.06 | $64.4K | 2,000 | SEC↗ |
| Pienta Kenneth | Chief Medical Officer | M Exercise | 2021-02-17 | 2021-02-18 | 2,994 | $5.00 | $15.0K | 6,274 | SEC↗ |
| Pienta Kenneth | Chief Medical Officer | M Exercise deriv | 2021-02-16 | 2021-02-18 | 16,000 | — | $0 | 1,280 | SEC↗ |
| Pienta Kenneth | Chief Medical Officer | M Exercise | 2021-02-16 | 2021-02-18 | 16,000 | $2.86 | $45.8K | 18,000 | SEC↗ |
| Pienta Kenneth | Chief Medical Officer | S Sale | 2021-02-16 | 2021-02-18 | 16,000 | $15.15 | $242.4K | 2,000 | SEC↗ |
| Millar Kerri-Ann | CFO | A Award deriv | 2021-02-10 | 2021-02-12 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Sandercock Colin | SVP, General Counsel and Sec | A Award deriv | 2021-02-10 | 2021-02-12 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PASSERI DANIEL R | CEO | A Award deriv | 2021-02-10 | 2021-02-12 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Suri Anish | President and CSO | A Award deriv | 2021-02-10 | 2021-02-12 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Pienta Kenneth | Chief Medical Officer | A Award deriv | 2021-02-10 | 2021-02-12 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Pienta Kenneth | Chief Medical Officer | M Exercise deriv | 2021-01-20 | 2021-02-18 | 2,720 | — | $0 | 17,280 | SEC↗ |
| Pienta Kenneth | Chief Medical Officer | P Buy | 2021-01-20 | 2021-01-22 | 2,720 | $15.07 | $41.0K | 4,720 | SEC↗ |
| Pienta Kenneth | Chief Medical Officer | S Sale | 2021-01-20 | 2021-02-18 | 2,720 | $15.07 | $41.0K | 2,000 | SEC↗ |
| Pienta Kenneth | Chief Medical Officer | M Exercise | 2021-01-20 | 2021-02-18 | 2,720 | $2.86 | $7.8K | 4,720 | SEC↗ |
| HOWSON TAMAR D | Director | A Award deriv | 2021-01-04 | 2021-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Gray Cameron | Director | A Award deriv | 2021-01-04 | 2021-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Fletcher Aaron G.L. | Director | A Award deriv | 2021-01-04 | 2021-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Morich Frank | Director | A Award deriv | 2021-01-04 | 2021-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DRISCOLL FREDERICK W | Director | A Award deriv | 2021-01-04 | 2021-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Kiener Peter A | Director | A Award deriv | 2021-01-04 | 2021-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Simon Barry J. | Director | A Award deriv | 2021-01-04 | 2021-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Fletcher Aaron G.L. | Director | P Buy | 2020-11-24 | 2020-11-25 | 6,548 | $12.64 | $82.8K | 165,000 | SEC↗ |
| Suri Anish | President and CSO | F Tax w/h | 2020-10-05 | 2020-10-06 | 9,800 | $16.30 | $159.7K | 58,091 | SEC↗ |
| Suri Anish | President and CSO | M Exercise deriv | 2020-10-03 | 2020-10-06 | 33,333 | — | $0 | 33,334 | SEC↗ |
| Suri Anish | President and CSO | M Exercise | 2020-10-03 | 2020-10-06 | 33,333 | — | $0 | 67,891 | SEC↗ |
| Gray Cameron | Director | P Buy | 2020-09-30 | 2020-10-01 | 5,000 | $15.30 | $76.5K | 677,500 | SEC↗ |
| Gray Cameron | Director | P Buy | 2020-09-29 | 2020-10-01 | 5,000 | $15.00 | $75.0K | 672,500 | SEC↗ |
| HOWSON TAMAR D | Director | A Award deriv | 2020-09-17 | 2020-09-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Millar Kerri-Ann | CFO | F Tax w/h | 2020-08-24 | 2020-08-25 | 1,900 | — | $0 | 5,766 | SEC↗ |
| Millar Kerri-Ann | CFO | A Award deriv | 2020-08-21 | 2020-08-25 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Millar Kerri-Ann | CFO | M Exercise deriv | 2020-08-21 | 2020-08-25 | 6,666 | — | $0 | 13,334 | SEC↗ |
| Millar Kerri-Ann | CFO | A Award deriv | 2020-08-21 | 2020-08-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Millar Kerri-Ann | CFO | M Exercise | 2020-08-21 | 2020-08-25 | 6,666 | — | $0 | 7,666 | SEC↗ |
| Suri Anish | President and CSO | M Exercise deriv | 2020-08-05 | 2020-08-07 | 800 | — | $0 | 145,000 | SEC↗ |
| Sandercock Colin | SVP, General Counsel and Sec | M Exercise deriv | 2020-08-05 | 2020-08-07 | 13,274 | — | $0 | 130,100 | SEC↗ |
| Sandercock Colin | SVP, General Counsel and Sec | M Exercise deriv | 2020-08-05 | 2020-08-10 | 13,374 | — | $0 | 130,000 | SEC↗ |
| Suri Anish | President and CSO | M Exercise | 2020-08-05 | 2020-08-07 | 800 | $6.42 | $5.1K | 35,358 | SEC↗ |
| Suri Anish | President and CSO | S Sale | 2020-08-05 | 2020-08-07 | 800 | $20.01 | $16.0K | 34,558 | SEC↗ |
| Sandercock Colin | SVP, General Counsel and Sec | S Sale | 2020-08-05 | 2020-08-07 | 13,274 | $20.00 | $265.5K | 17,125 | SEC↗ |
| Sandercock Colin | SVP, General Counsel and Sec | M Exercise | 2020-08-05 | 2020-08-07 | 13,274 | $7.50 | $99.6K | 30,399 | SEC↗ |
| Sandercock Colin | SVP, General Counsel and Sec | M Exercise | 2020-08-05 | 2020-08-10 | 13,374 | $7.50 | $100.3K | 30,499 | SEC↗ |
| Sandercock Colin | SVP, General Counsel and Sec | S Sale | 2020-08-05 | 2020-08-10 | 13,374 | $20.00 | $267.5K | 17,125 | SEC↗ |
| Suri Anish | President and CSO | M Exercise deriv | 2020-08-04 | 2020-08-05 | 400 | — | $0 | 145,800 | SEC↗ |
| Sandercock Colin | SVP, General Counsel and Sec | M Exercise deriv | 2020-08-04 | 2020-08-05 | 201 | — | $0 | 143,374 | SEC↗ |
| Suri Anish | President and CSO | M Exercise | 2020-08-04 | 2020-08-05 | 400 | $6.42 | $2.6K | 34,958 | SEC↗ |
| Suri Anish | President and CSO | S Sale | 2020-08-04 | 2020-08-05 | 400 | $20.14 | $8.1K | 34,558 | SEC↗ |
| Sandercock Colin | SVP, General Counsel and Sec | S Sale | 2020-08-04 | 2020-08-05 | 201 | $20.05 | $4.0K | 17,125 | SEC↗ |
| Sandercock Colin | SVP, General Counsel and Sec | M Exercise | 2020-08-04 | 2020-08-05 | 201 | $7.50 | $1.5K | 17,326 | SEC↗ |
| Suri Anish | President and CSO | M Exercise deriv | 2020-08-03 | 2020-08-05 | 3,800 | — | $0 | 146,200 | SEC↗ |
| Suri Anish | President and CSO | M Exercise deriv | 2020-08-03 | 2020-08-05 | 2,000 | — | $0 | 18,000 | SEC↗ |
| Sandercock Colin | SVP, General Counsel and Sec | M Exercise deriv | 2020-08-03 | 2020-08-05 | 6,425 | — | $0 | 143,575 | SEC↗ |
| Suri Anish | President and CSO | S Sale | 2020-08-03 | 2020-08-05 | 5,800 | $20.01 | $116.1K | 34,558 | SEC↗ |
| Suri Anish | President and CSO | M Exercise | 2020-08-03 | 2020-08-05 | 2,000 | $8.26 | $16.5K | 36,558 | SEC↗ |
| Suri Anish | President and CSO | M Exercise | 2020-08-03 | 2020-08-05 | 3,800 | $6.42 | $24.4K | 40,358 | SEC↗ |
| Sandercock Colin | SVP, General Counsel and Sec | M Exercise | 2020-08-03 | 2020-08-05 | 6,425 | $7.50 | $48.2K | 23,550 | SEC↗ |
| Sandercock Colin | SVP, General Counsel and Sec | S Sale | 2020-08-03 | 2020-08-05 | 6,425 | $20.00 | $128.5K | 17,125 | SEC↗ |
| Fletcher Aaron G.L. | Director | P Buy | 2020-06-24 | 2020-06-25 | 4,547 | $24.64 | $112.0K | 155,499 | SEC↗ |
| Fletcher Aaron G.L. | Director | P Buy | 2020-06-24 | 2020-06-25 | 2,953 | $25.24 | $74.5K | 158,452 | SEC↗ |
| Morich Frank | Director | A Award deriv | 2020-05-11 | 2020-05-12 | 1,200 | — | $0 | 1,200 | SEC↗ |
| Suri Anish | President and CSO | A Award deriv | 2020-03-31 | 2020-04-10 | 50,000 | — | $0 | 116,667 | SEC↗ |
| Suri Anish | President and CSO | M Exercise deriv | 2020-03-31 | 2020-04-10 | 16,666 | — | $0 | 100,001 | SEC↗ |
| Suri Anish | President and CSO | M Exercise | 2020-03-31 | 2020-04-10 | 16,666 | — | $0 | 39,912 | SEC↗ |
| Suri Anish | President and CSO | F Tax w/h | 2020-03-31 | 2020-04-10 | 5,354 | — | $0 | 34,558 | SEC↗ |
| Pienta Kenneth | Chief Medical Officer | A Award deriv | 2020-03-24 | 2020-03-26 | 100,000 | — | $0 | 100,000 | SEC↗ |
| PASSERI DANIEL R | CEO | A Award deriv | 2020-02-05 | 2020-02-12 | 150,000 | — | $0 | 150,000 | SEC↗ |
| PASSERI DANIEL R | CEO | A Award deriv | 2020-02-05 | 2020-02-12 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Suri Anish | President and CSO | A Award deriv | 2020-02-05 | 2020-02-12 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Millar Kerri-Ann | VP-Finance | A Award deriv | 2020-02-05 | 2020-02-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Sandercock Colin | SVP, General Counsel and Sec | A Award deriv | 2020-02-05 | 2020-02-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Fletcher Aaron G.L. | Director | A Award deriv | 2020-01-02 | 2020-01-06 | 8,000 | — | $0 | 8,000 | SEC↗ |
| DRISCOLL FREDERICK W | Director | A Award deriv | 2020-01-02 | 2020-01-06 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Gray Cameron | Director | A Award deriv | 2020-01-02 | 2020-01-06 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Kiener Peter A | Director | A Award deriv | 2020-01-02 | 2020-01-06 | 8,000 | — | $0 | 8,000 | SEC↗ |
| MARLETT CHRISTOPHER A | Director | A Award deriv | 2020-01-02 | 2020-01-06 | 8,000 | — | $0 | 8,000 | SEC↗ |
| MCKNIGHT STEVEN L | Director | A Award deriv | 2020-01-02 | 2020-01-06 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Morich Frank | Director | A Award deriv | 2020-01-02 | 2020-01-06 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Simon Barry J. | Director | A Award deriv | 2020-01-02 | 2020-01-06 | 9,600 | — | $0 | 9,600 | SEC↗ |
| MARLETT CHRISTOPHER A | Director | S Sale | 2019-12-31 | 2019-12-31 | 6,700 | $15.77 | $105.7K | 768,503 | SEC↗ |
| MARLETT CHRISTOPHER A | Director | S Sale | 2019-12-31 | 2019-12-31 | 9,000 | $15.71 | $141.4K | 0 | SEC↗ |
| MARLETT CHRISTOPHER A | Director | S Sale | 2019-12-27 | 2019-12-31 | 9,000 | $17.24 | $155.2K | 775,203 | SEC↗ |
| MARLETT CHRISTOPHER A | Director | S Sale | 2019-12-26 | 2019-12-27 | 19,647 | $17.53 | $344.4K | 784,203 | SEC↗ |
| MARLETT CHRISTOPHER A | Director | S Sale | 2019-12-23 | 2019-12-27 | 17,000 | $16.82 | $285.9K | 803,850 | SEC↗ |
| MARLETT CHRISTOPHER A | Director | S Sale | 2019-12-19 | 2019-12-19 | 4,000 | $17.00 | $68.0K | 820,850 | SEC↗ |
| MARLETT CHRISTOPHER A | Director | S Sale | 2019-12-17 | 2019-12-19 | 20,732 | $15.73 | $326.1K | 824,850 | SEC↗ |
| MARLETT CHRISTOPHER A | Director | J Other | 2019-12-12 | 2019-12-19 | 1,007,973 | — | $0 | 0 | SEC↗ |
| MARLETT CHRISTOPHER A | Director | J Other | 2019-12-12 | 2019-12-19 | 755,980 | — | $0 | 845,582 | SEC↗ |
| Suri Anish | President and CSO | M Exercise deriv | 2019-11-01 | 2019-11-04 | 33,333 | — | $0 | 66,667 | SEC↗ |